| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/24/2005 | US20050042299 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 02/24/2005 | US20050042272 Vesiles derived from t cells, production and uses |
| 02/24/2005 | US20050042254 Aligned scaffolds for improved myocardial regeneration |
| 02/24/2005 | US20050042234 Method |
| 02/24/2005 | US20050042224 Methods and products related to metabolic interactions in disease |
| 02/24/2005 | US20050042210 Body tissue filling material, production method thereof and body tissue filler |
| 02/24/2005 | US20050042208 Incubating precursor cell capable of differentiating to cytotoxic T cell with antigen presenting cell in presence of substance having binding activity to CD44, fibronectin, regulator of signal emitted by growth factor, and/or inhibitor of binding to growth factor receptor; immunotherapy |
| 02/24/2005 | US20050042207 Escherichia bacteria; diarrhea, autoimmune diseases, microbial infections, irritable bowel syndrome, and inflammatory bowel disease; side effect reduction |
| 02/24/2005 | US20050042206 Viral vectors having reduced virulence |
| 02/24/2005 | US20050042202 Gentamicin, amikacin, tobramycin, netilmicin, cephalosporin, ceftazidine, maxalactam, carbopenem, imipenem, aztreonam, ampicillin, penicillin, ureidopenicillin, augmentin, amphotericin, famvir and/or acyclovir; and Vpr protein, fragment or nucleic acid encoding; systemic inflammatory response syndrome |
| 02/24/2005 | US20050042198 Ophthalmic and contact lens wetting solutions |
| 02/24/2005 | CA2535892A1 A stable liquid probiotic composition, preparation and applications thereof |
| 02/24/2005 | CA2535685A1 Method of generating neural stem cells |
| 02/24/2005 | CA2535683A1 Stem cell beacon |
| 02/24/2005 | CA2535680A1 Vigilant cells |
| 02/24/2005 | CA2535618A1 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
| 02/24/2005 | CA2535261A1 Prion-specific peptide reagents |
| 02/24/2005 | CA2534922A1 Composition comprising a zeolite compound for treatment of diseases |
| 02/24/2005 | CA2534887A1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds |
| 02/24/2005 | CA2533641A1 Lactoperoxidase as an osteogenesis promoter |
| 02/24/2005 | CA2528938A1 Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 02/24/2005 | CA2525670A1 Hair regenerator |
| 02/24/2005 | CA2497198A1 Agents and methods for treatment of disease by oligosaccharide targeting agents |
| 02/23/2005 | EP1508345A1 Absorbents and devices for the reduction of small organic compounds from blood products |
| 02/23/2005 | EP1508336A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 02/23/2005 | EP1507863A1 Plasmid stabilisation in vivo |
| 02/23/2005 | EP1507853A1 Palliative treatment for gluten intolerance |
| 02/23/2005 | EP1507850A1 A method for generating antigen-presenting cells |
| 02/23/2005 | EP1507849A1 Methods and compositions for expanding and differentiating insulin-producing cells |
| 02/23/2005 | EP1507848A1 Expansion and transdifferentiation of human acinar cells |
| 02/23/2005 | EP1507847A2 Treatments with autologous fibroblast |
| 02/23/2005 | EP1507553A2 Pancreas-specific proteins |
| 02/23/2005 | EP1507552A2 Methods, compositions, and growth and differentiation factors for insulin-producing cells |
| 02/23/2005 | EP1507548A1 Method for determining immune system affecting compounds |
| 02/23/2005 | EP1507543A1 A pharmaceutical composition for treatment of wounds containing blood plasma or serum |
| 02/23/2005 | EP1507517A1 Microparticles bearing cells and active substances |
| 02/23/2005 | EP1507454A1 Animal model for toxicology and dose prediction |
| 02/23/2005 | EP1315829A4 Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof |
| 02/23/2005 | CN1585648A Enamel matrix protein compositions for modulating immune response |
| 02/23/2005 | CN1585642A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/23/2005 | CN1584020A Differentiation of adipose stromal cells into osteobalsts and uses thereof |
| 02/23/2005 | CN1583164A Preparing procedure of transfer factor for intravenous injection |
| 02/23/2005 | CN1583162A Injection of donkey hide gelatin and its preparation |
| 02/23/2005 | CN1582971A Blood fat reducing preparation and its preparing method and use |
| 02/23/2005 | CN1582970A Extraction of effective portion of gryllotalpidae for anti-cancers and its preparation |
| 02/23/2005 | CN1582969A Chinese medicine for lymphnode tuberculosis and its preparation |
| 02/23/2005 | CN1582968A Preparation of water soluble pearl liquid |
| 02/23/2005 | CN1582967A Preparation of stable suspension of nano pearls powder |
| 02/23/2005 | CN1582966A Preparation of nano pearls powder |
| 02/23/2005 | CN1582965A Double ginseng capsules and their preparation |
| 02/23/2005 | CN1582964A Sheep fetus health care products and their products |
| 02/23/2005 | CN1582963A Preparation of biochemical nutrients for ostrich |
| 02/23/2005 | CN1582962A Capsules of complete active substances of pilose antler and their preparation |
| 02/23/2005 | CN1582754A Nutrient food for increasing immunity and relaking fatigue |
| 02/23/2005 | CN1582753A Yak marrow powder health care product and its making method |
| 02/23/2005 | CN1190235C Process for preparing health-care compound sheep placenta extract food series |
| 02/23/2005 | CN1190233C Anti-neoplasm medicine and its preparation method |
| 02/23/2005 | CN1190229C Medicine for curing hepatitis B |
| 02/23/2005 | CN1190228C 'Angong' hemostaics |
| 02/23/2005 | CN1190226C External used germinal pharmaceutics and preparation process thereof |
| 02/23/2005 | CN1190225C Oral preparation for hair-growing and its making process |
| 02/23/2005 | CN1190224C Medicine for treating stomach troubles |
| 02/23/2005 | CN1190221C Medicine for curing hepatitis B |
| 02/23/2005 | CN1190218C Chinese medicine for treating hyperosteogeny |
| 02/23/2005 | CN1190216C Medicine for treating lumber intervertebral disk protrusion and its preparing process |
| 02/23/2005 | CN1190215C Chinese herbal medicine for treating rheumatism |
| 02/23/2005 | CN1190210C Medical wine for treating hyperosteogeny and its preparing method |
| 02/23/2005 | CN1190209C Oral cavity ulcer powder and preparation thereof |
| 02/23/2005 | CN1190207C Medicine for withdrawal of drug addiction and preparing process thereof |
| 02/23/2005 | CN1190204C Medicine for treating hyperosteogeny in cervical vertebra and lumbar vertebra |
| 02/23/2005 | CN1190202C Fat-soluble suppository containing lactobacillus and its preparation method |
| 02/23/2005 | CN1190149C Method for separating functional factor from royal jelly |
| 02/22/2005 | US6858578 Chimeric proteins for use in transport of a selected substance into cells |
| 02/22/2005 | US6858232 Topical transdermal treatments |
| 02/22/2005 | US6858201 Methods for treating fingernails and toenails |
| 02/22/2005 | CA2275367C Absorbable composition containing propionic bacteria capable of releasing nitric oxide in the human or animal alimentary canal |
| 02/22/2005 | CA2093022C Targeted immunostimulation with bispecific reagents |
| 02/19/2005 | CA2457296A1 Methods for inducing differentiation of pluripotent cells |
| 02/17/2005 | WO2005014799A1 Conditioned cell culture medium, method to obtain the same and use of it for maintenance, proliferation and differentiation of mammalian cells |
| 02/17/2005 | WO2005014019A1 Markov therapeutic and preventive compound |
| 02/17/2005 | WO2005014017A1 Medicinal composition for treating cancer |
| 02/17/2005 | WO2005014016A1 Compositions containing macrophages and uses thereof |
| 02/17/2005 | WO2005014015A1 Compositions containing macrophages and uses thereof |
| 02/17/2005 | WO2005014014A1 Method for inhibiting bacterial colonisation |
| 02/17/2005 | WO2005013920A2 Newcastle disease virus administration |
| 02/17/2005 | WO2004105837A3 Compounds and methods for improving platelet recovery and function |
| 02/17/2005 | WO2004104493A3 Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same |
| 02/17/2005 | WO2004091435A3 Osteoinductive bone material |
| 02/17/2005 | WO2004090118A8 Lactobacillus plantarum strain st-iii and its use in adjusting blood fat |
| 02/17/2005 | WO2004089278A3 Sexual hygienic composition |
| 02/17/2005 | WO2004046310A3 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 02/17/2005 | WO2004009028A3 Method and composition for treating and preventing influenza infection and symptoms thereof |
| 02/17/2005 | WO2003101396A3 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 02/17/2005 | US20050038492 Method for forming matrices of hardened material |
| 02/17/2005 | US20050037976 Hematopoietic stimulation |
| 02/17/2005 | US20050037949 Mannose binding lectin and uses thereof |
| 02/17/2005 | US20050037491 Repair and regeneration of ocular tissue using postpartum-derived cells |
| 02/17/2005 | US20050037489 Methods of generating human cardiac cells and tissues and uses thereof |
| 02/17/2005 | US20050037488 Human pluripotent stem cell culture for use in regenerative medicine and tissue repair; tissue engineering and gene therapy |
| 02/17/2005 | US20050037469 Fusion polypeptide comprising a collagen-binding domain and an epithelial cell proliferation-modulating domain for use as tool in regenerative medicine and tissue repair |